Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Am J Physiol Cell Physiol ; 319(3): C500-C509, 2020 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-32687406

RESUMO

Severe acute respiratory syndrome coronavirus (SARS-CoV), an enveloped virus with a positive-sense single-stranded RNA genome, facilitates the host cell entry through intricate interactions with proteins and lipids of the cell membrane. The detailed molecular mechanism involves binding to the host cell receptor and fusion at the plasma membrane or after being trafficked to late endosomes under favorable environmental conditions. A crucial event in the process is the proteolytic cleavage of the viral spike protein by the host's endogenous proteases that releases the fusion peptide enabling fusion with the host cellular membrane system. The present review details the mechanism of viral fusion with the host and highlights the therapeutic options that prevent SARS-CoV-2 entry in humans.


Assuntos
Betacoronavirus/metabolismo , Membrana Celular/metabolismo , Infecções por Coronavirus/metabolismo , Infecções por Coronavirus/prevenção & controle , Pandemias/prevenção & controle , Pneumonia Viral/metabolismo , Pneumonia Viral/prevenção & controle , Proteínas Virais de Fusão/metabolismo , Sequência de Aminoácidos , Enzima de Conversão de Angiotensina 2 , Animais , Betacoronavirus/efeitos dos fármacos , COVID-19 , Membrana Celular/efeitos dos fármacos , Membrana Celular/virologia , Humanos , Peptidil Dipeptidase A/metabolismo , Inibidores de Proteases/farmacologia , Inibidores de Proteases/uso terapêutico , Ligação Proteica/efeitos dos fármacos , Ligação Proteica/fisiologia , SARS-CoV-2 , Glicoproteína da Espícula de Coronavírus/antagonistas & inibidores , Glicoproteína da Espícula de Coronavírus/metabolismo , Proteínas Virais de Fusão/efeitos dos fármacos
2.
Cancer Metastasis Rev ; 37(2-3): 519-544, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-29860560

RESUMO

The cell plasma membrane serves as a nexus integrating extra- and intracellular components, which together enable many of the fundamental cellular signaling processes that sustain life. In order to perform this key function, plasma membrane components assemble into well-defined domains exhibiting distinct biochemical and biophysical properties that modulate various signaling events. Dysregulation of these highly dynamic membrane domains can promote oncogenic signaling. Recently, it has been demonstrated that select membrane-targeted dietary bioactives (MTDBs) have the ability to remodel plasma membrane domains and subsequently reduce cancer risk. In this review, we focus on the importance of plasma membrane domain structural and signaling functionalities as well as how loss of membrane homeostasis can drive aberrant signaling. Additionally, we discuss the intricacies associated with the investigation of these membrane domain features and their associations with cancer biology. Lastly, we describe the current literature focusing on MTDBs, including mechanisms of chemoprevention and therapeutics in order to establish a functional link between these membrane-altering biomolecules, tuning of plasma membrane hierarchal organization, and their implications in cancer prevention.


Assuntos
Membrana Celular/metabolismo , Neoplasias/etiologia , Neoplasias/metabolismo , Animais , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Fenômenos Bioquímicos , Biomarcadores , Fenômenos Biofísicos , Membrana Celular/química , Membrana Celular/efeitos dos fármacos , Quimioprevenção , Suplementos Nutricionais , Humanos , Metabolismo dos Lipídeos , Lipídeos de Membrana/metabolismo , Microdomínios da Membrana/química , Microdomínios da Membrana/metabolismo , Proteínas de Membrana/metabolismo , Neoplasias/patologia , Neoplasias/prevenção & controle , Transdução de Sinais
3.
Ecotoxicol Environ Saf ; 183: 109507, 2019 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-31386942

RESUMO

Multi-walled carbon nanotubes (MWCNTs) promote biodegradation in water treatment, but the effect of MWCNT on denitrification under aerobic conditions is still unclear. This investigation focused on the denitrification performance of MWCNT and its toxic effects on Alcaligenes sp. TB which showed that 30 mg/L MWCNTs increased NO3- removal efficiency from 84% to 100% and decreased the NO2-and N2O accumulation rates by 36% and 17.5%, respectively. Nitrite reductase and nitrous oxide reductase activities were further increased by 19.5% and 7.5%, respectively. The mechanism demonstrated that electron generation (NADH yield) and electron transportation system activity increased by 14.5% and 104%, respectively. Cell membrane analysis found that MWCNT caused an increase in polyunsaturated fatty acids, which had positive effects on electron transportation and membrane fluidity at a low concentration of 96 mg/kg but caused membrane lipid peroxidation and impaired membrane integrity at a high concentration of 115 mg/L. These findings confirmed that MWCNT affects the activity of Alcaligenes sp. TB and consequently enhances denitrification performance.


Assuntos
Alcaligenes/metabolismo , Desnitrificação/fisiologia , Nanotubos de Carbono , Purificação da Água/métodos , Biodegradação Ambiental , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Desnitrificação/efeitos dos fármacos , Transporte de Elétrons , Ácidos Graxos Insaturados/metabolismo , NAD/metabolismo , Nanotubos de Carbono/toxicidade , Nitratos/isolamento & purificação
5.
J Exp Bot ; 62(8): 2645-56, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21282326

RESUMO

Calcium (Ca) uptake into fruit and leaves is dependent on xylemic water movement, and hence presumably driven by transpiration and growth. High leaf transpiration is thought to restrict Ca movement to low-transpiring tomato fruit, which may increase fruit susceptibility to the Ca-deficiency disorder, blossom end rot (BER). The objective of this study was to analyse the effect of reduced leaf transpiration in abscisic acid (ABA)-treated plants on fruit and leaf Ca uptake and BER development. Tomato cultivars Ace 55 (Vf) and AB2 were grown in a greenhouse environment under Ca-deficit conditions and plants were treated weekly after pollination with water (control) or 500 mg l(-1) ABA. BER incidence was completely prevented in the ABA-treated plants and reached values of 30-45% in the water-treated controls. ABA-treated plants had higher stem water potential, lower leaf stomatal conductance, and lower whole-plant water loss than water-treated plants. ABA treatment increased total tissue and apoplastic water-soluble Ca concentrations in the fruit, and decreased Ca concentrations in leaves. In ABA-treated plants, fruit had a higher number of Safranin-O-stained xylem vessels at early stages of growth and development. ABA treatment reduced the phloem/xylem ratio of fruit sap uptake. The results indicate that ABA prevents BER development by increasing fruit Ca uptake, possibly by a combination of whole-plant and fruit-specific mechanisms.


Assuntos
Ácido Abscísico/farmacologia , Cálcio/metabolismo , Flores/metabolismo , Frutas/metabolismo , Doenças das Plantas/prevenção & controle , Solanum lycopersicum/metabolismo , Biomassa , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Flores/efeitos dos fármacos , Frutas/efeitos dos fármacos , Solanum lycopersicum/efeitos dos fármacos , Especificidade de Órgãos/efeitos dos fármacos , Floema/efeitos dos fármacos , Floema/metabolismo , Folhas de Planta/efeitos dos fármacos , Folhas de Planta/metabolismo , Água/farmacologia , Xilema/efeitos dos fármacos , Xilema/metabolismo
6.
Drug Des Devel Ther ; 13: 4291-4303, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31908415

RESUMO

Emerging evidence of significant hearing loss occurring shortly after cisplatin administration in cancer patients has stimulated research into the causes and treatment of this side effect. Although the aetiology of cisplatin-induced hearing loss (CIHL) remains unknown, an increasing body of research suggests that it is associated with excessive generation of intracellular reactive oxygen species (ROS) in the cochlea. Astaxanthin, a xanthophyll carotenoid, has powerful anti-oxidant, anti-inflammatory, and anti-apoptotic properties based on its unique cell membrane function, diverse biological activities, and ability to permeate the blood-brain barrier. In this review, we summarize the role of ROS in CIHL and the effect of astaxanthin on inhibiting ROS production. We focus on investigating the mechanism of action of astaxanthin in suppressing excessive production of ROS.


Assuntos
Cisplatino/efeitos adversos , Cisplatino/antagonistas & inibidores , Sequestradores de Radicais Livres/farmacologia , Perda Auditiva/prevenção & controle , Espécies Reativas de Oxigênio/metabolismo , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Cisplatino/uso terapêutico , Sequestradores de Radicais Livres/metabolismo , Perda Auditiva/tratamento farmacológico , Humanos , Xantofilas/metabolismo , Xantofilas/farmacologia
7.
Eksp Klin Gastroenterol ; (4): 103-7, 2008.
Artigo em Russo | MEDLINE | ID: mdl-19145910

RESUMO

The high effectiveness of metabolic medication in acute pancreatitis therapy was demonstrated by experimental and clinical researches. The medication capability for knocking-over of systemic lipid distress-syndrome determines its membraneprotective effect, which promotes correction of functional disorders of different organs cell structures and decrease of intoxication syndrome. The expressed lipid corrective effect of metabolic therapy determines major pathogenesis component of its high clinical effectiveness under acute pancreatitis, that confirms important role of lipid modificated component of cell structures membrane by metabolic therapy in knocking-over of acute pancreas inflammation.


Assuntos
Antioxidantes/uso terapêutico , Membrana Celular/efeitos dos fármacos , Metabolismo dos Lipídeos/efeitos dos fármacos , Pancreatite/tratamento farmacológico , Doença Aguda , Animais , Antioxidantes/administração & dosagem , Antioxidantes/metabolismo , Membrana Celular/metabolismo , Cães , Quimioterapia Combinada , Humanos , Pancreatite/diagnóstico , Pancreatite/enzimologia , Pancreatite/metabolismo , Resultado do Tratamento
8.
Front Biosci (Landmark Ed) ; 23(10): 1780-1788, 2018 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-29772528

RESUMO

Morbidity and mortality associated with diarrheal diseases remain significant burdens on global health. In the developing world, the major sources of secretory diarrhea are infectious, including those caused by bacteria such as enterotoxic Escherichia coli, and viruses such as rotavirus. In many cases of secretory diarrhea, activation of pathways for cyclic nucleotides and/or Ca2+ signaling in the apical membrane of enterocytes increases the conductance of Cl- channels at the enterocyte lumen-facing membrane. Those channels include the cystic fibrosis transmembrane conductance regulator (CFTR) and Ca2+-activated Cl- channel (CaCC). Inhibition of enterocyte Cl- channels is an effective strategy for anti-secretory drug therapy. Small molecules and natural peptides with Cl- channel inhibitory activity have shown efficacy in diarrhea models. Screening of natural peptides via the patch-clamp technique provides evidence that such channel inhibition by an extract of black tea may be responsible for its anti-diarrhea benefits.


Assuntos
Canais de Cloreto/antagonistas & inibidores , Diarreia/prevenção & controle , Enterócitos/efeitos dos fármacos , Peptídeos/farmacologia , Animais , Cálcio/metabolismo , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Canais de Cloreto/metabolismo , AMP Cíclico/metabolismo , Regulador de Condutância Transmembrana em Fibrose Cística/antagonistas & inibidores , Regulador de Condutância Transmembrana em Fibrose Cística/metabolismo , Diarreia/metabolismo , Enterócitos/metabolismo , Humanos , Bibliotecas de Moléculas Pequenas/farmacologia
9.
PLoS One ; 13(1): e0190932, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29320571

RESUMO

The fungal pathogen Botrytis cinerea causes gray mold disease on various hosts, which results in serious economic losses. Over the past several decades, many kinds of fungicides have been used to successfully control the disease. Meanwhile, the uses of fungicides lead to environmental pollution as well as a potential threat to the human health by the chemical residues in tomato fruit. Also, the gray mold disease is difficult to control with fungicides. Therefore, exploring alternative measures such as biological controls could be the best choice to control the disease and alleviate damages caused by fungicides. In this study, we isolated and identified a novel Pseudomonas strain termed as QBA5 from healthy tomato plant based on the morphological, biochemical characteristics and molecular detection. The antifungal activity assays revealed that, in the presence of QBA5, conidia germination, germ tube elongation and mycelial growth of B. cinerea were significantly inhibited. Most importantly, QBA5 exerted a significant preventive effectiveness against gray mold on tomato fruits and plants. The possible mechanism of QBA5 involved in the inhibition of B. cinerea was investigated. It revealed that the conidia plasma membrane of B. cinerea was severely damaged by QBA5. Further, four different antifungal compounds in the supernatant of QBA5 were separated by preparative high performance liquid chromatography (PHPLC). Overall, the data indicate that there is a considerable potential for QBA5 to reduce the damage caused by gray mold disease on tomato.


Assuntos
Antibiose , Botrytis/fisiologia , Frutas/microbiologia , Doenças das Plantas/microbiologia , Folhas de Planta/microbiologia , Pseudomonas/fisiologia , Solanum lycopersicum/microbiologia , Antifúngicos/química , Antifúngicos/farmacologia , Botrytis/efeitos dos fármacos , Membrana Celular/efeitos dos fármacos , Membrana Celular/fisiologia , Meios de Cultura/química , Frutas/efeitos dos fármacos , Solanum lycopersicum/efeitos dos fármacos , Doenças das Plantas/prevenção & controle , Doenças das Plantas/terapia , Folhas de Planta/efeitos dos fármacos , Pseudomonas/isolamento & purificação , Esporos Fúngicos/efeitos dos fármacos , Esporos Fúngicos/fisiologia
10.
Trends Pharmacol Sci ; 15(3): 83-9, 1994 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8184491

RESUMO

Tamoxifen protects membranes and lipoprotein particles against oxidative damage. This antioxidant action is likely to contribute to the observed cardioprotective action of tamoxifen and supports the use of this compound in treating and even preventing breast cancer. Membrane-mediated mechanisms of tamoxifen action, through a putative modulation of membrane fluidity, are likely to play an important role in its anticancer action and its ability to reverse multidrug resistance, and could also lead to clinical uses as an anti-Candida and anti-viral agent. In this review, Helen Wiseman discusses the interaction of tamoxifen with membranes and lipoprotein particles, and considers the possible clinical implications.


Assuntos
Tamoxifeno/farmacologia , Tamoxifeno/uso terapêutico , Animais , Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Antivirais/uso terapêutico , Neoplasias da Mama/prevenção & controle , Candida/efeitos dos fármacos , Doenças Cardiovasculares/prevenção & controle , Membrana Celular/efeitos dos fármacos , Humanos , Relação Estrutura-Atividade , Tamoxifeno/química
11.
Magnes Res ; 7(3-4): 289-94, 1994 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7786693

RESUMO

The results of an open randomized study on magnesium status and parenteral magnesium sulphate therapy in acute aluminium phosphide intoxication are presented. The study was conducted on 105 patients divided into two group (I & II). Patients of Group I did not receive parenteral magnesium and acted as blank. Magnesium levels were monitored every 6 h for 24 h. Patients of group II received magnesium sulphate therapy. It was administered as 1.0 g (8.1 mEq or 4.05 mmol) magnesium sulphate dissolved in 100 ml of 5 per cent dextrose intravenously as a bolus dose followed by 1.0 g every hour for three successive hours, then 1.0 g every 6 h as a maintenance dose for the next 24 h as intravenous infusion in 5 per cent dextrose. The total dose of magnesium sulphate infused was 30.0 mmol over a period of 24 h (initial dose), then 16.0 mmol (4.0 g) daily till final outcome or a maximum of five days. All the vital parameters were monitored. All the patients were followed till final outcome. The resuscitation methods used were the same in both groups. At the end of the study, mortality rates were calculated in both groups. Hypomagnesaemia was observed as the constant finding in patients of Group I. It was transient and reversed itself without MgSO4. The mortality rate was 52 per cent. On the other hand, magnesium levels rose immediately after parenteral MgSO4 administration in patients of group II and they remained persistently above normal during the observed period.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Compostos de Alumínio/intoxicação , Arritmias Cardíacas/prevenção & controle , Sulfato de Magnésio/uso terapêutico , Magnésio/sangue , Fosfinas/intoxicação , Doença Aguda , Adulto , Arritmias Cardíacas/induzido quimicamente , Membrana Celular/efeitos dos fármacos , Feminino , Humanos , Infusões Intravenosas , Sulfato de Magnésio/administração & dosagem , Masculino , Intoxicação/mortalidade
12.
Expert Rev Anti Infect Ther ; 10(8): 917-34, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23030331

RESUMO

The emergence of multidrug-resistant Gram-negative bacteria that cause nosocomial infections is a growing problem worldwide. Colistin was first introduced in 1952 and was used until the early 1980s for the treatment of infections caused by Gram-negative bacilli. In vitro, colistin has demonstrated excellent activity against various Gram-negative rod-shaped bacteria, including multidrug-resistant Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae. Recent clinical findings regarding colistin activity, pharmacokinetic properties, clinical uses, emerging resistance, toxicities and combination therapy have been reviewed. Recent approaches to the use of colistin in combination with other antibiotics hold promise for increased antibacterial efficacy. It is probable that colistin will be the 'last-line' therapeutic drug against multidrug-resistant Gram-negative pathogens in the 21st century.


Assuntos
Antibacterianos/farmacologia , Colistina/farmacologia , Infecções por Klebsiella/tratamento farmacológico , Infecções por Pseudomonas/tratamento farmacológico , Infecções por Acinetobacter/tratamento farmacológico , Acinetobacter baumannii/patogenicidade , Antibacterianos/administração & dosagem , Antibacterianos/farmacocinética , Membrana Celular/efeitos dos fármacos , Colistina/administração & dosagem , Colistina/farmacocinética , Farmacorresistência Bacteriana Múltipla , Quimioterapia Combinada , Humanos , Klebsiella pneumoniae/patogenicidade , Polimixina B/administração & dosagem , Polimixina B/farmacologia , Pseudomonas aeruginosa/patogenicidade , Resultado do Tratamento
13.
Med Hypotheses ; 74(5): 825-30, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20044213

RESUMO

BACKGROUND: The Maya of Central America are credited with the first consumption of cocoa and maintaining its ancient Olmec name kakawa translated in English as "God Food", in recognition of its multiple health benefits. The legend of cocoa is receiving renewed attention in recent years, on account of epidemiological and scientific studies that support its cardiovascular health benefits. Increasing numbers of scientific reports corroborating cocoa's antiquated reputation as health food persuaded this author to promote regular consumption of cocoa in Ghana since 2004. Cocoa is readily available in Ghana; the country is the second largest producer accounting for 14% of the world's output. Numerous anecdotal reports of reduced episodic malaria in people who daily drink natural unsweetened cocoa beverage prompted a search for scientific mechanisms that possibly account for cocoa's antimalarial effects. This paper presents the outcome as a hypothesis. METHODS: Internet search for literature on effects of cocoa's ingredients on malaria parasites and illness using a variety of search tools. RESULTS: Evidential literature suggests five mechanisms that possibly underpin cocoa's anecdotal antimalarial effects. (i) Increased availability of antioxidants in plasma, (ii) membrane effects in general and erythrocyte membrane in particular, (iii) increased plasma levels of nitric oxide, (iv) antimalarial activity of cocoa flavanoids and their derivatives, and (v) boosted immune system mediated by components of cocoa including cocoa butter, polyphenols, magnesium, and zinc. CONCLUSION: A hypothesis is formulated that cocoa offers a diet-mediated antimalarial prophylaxis; and an additional novel tool in the fight against the legendary scourge.


Assuntos
Antioxidantes/farmacologia , Cacau/química , Quimioprevenção/métodos , Malária/prevenção & controle , Preparações de Plantas/farmacologia , Antioxidantes/uso terapêutico , Membrana Celular/efeitos dos fármacos , Flavonoides/farmacologia , Humanos , Malária/tratamento farmacológico , Óxido Nítrico/sangue , Fenóis/farmacologia , Preparações de Plantas/uso terapêutico , Polifenóis , Proantocianidinas/farmacologia , Teobromina/farmacologia
18.
Rev. Esc. Enferm. USP ; Rev. Esc. Enferm. USP;48(spe): 53-58, 08/2014.
Artigo em Inglês | LILACS, BDENF - enfermagem (Brasil) | ID: lil-731286

RESUMO

Objective To understand the experiences and expectations of nurses in the treatment of women with chronic venous ulcers. Method Phenomenological research was based on Alfred Schütz, whose statements were obtained in January, 2012, through semi-structured interviews with seven nurses. Results The nurse reveals the difficulties presented by the woman in performing self-care, the perceived limitations in the treatment anchored in motivation, and the values and beliefs of women. It showed professional frustration because venous leg ulcer recurrence, lack of inputs, interdisciplinary work and training of nursing staff. There was an expected adherence to the treatment of women, and it emphasized the need for ongoing care, supported self-care and standard practices in treatment. Conclusion That treatment of chronic venous leg ulcers constitutes a challenge that requires collective investment, involving women, professionals, managers and health institutions. .


Objetivo Comprender las experiencias y expectativas de enfermeras en el tratamiento de mujeres con úlcera venosa crónica. Método Investigación fenomenológica fundamentada en Alfred Schutz, que buscó Se realizó entrevista semiestructurada con siete enfermeras, en enero del 2012. Resultados La enfermera revela dificultades presentadas por la mujer para realizar el autocuidado, percibe limitaciones en el tratamiento relacionadas con la desmotivación, los valores y las creencias de las mujeres. Refiere frustración profesional debido a la recidiva de la lesión, a la falta de insumos, al deficiente trabajo interdisciplinar y a la limitada capacitación del equipo de enfermeras. Espera la adhesión de la mujer al tratamiento y resalta la necesidad del cuidado continuo, del autocuidado apoyado y de estandarizar conductas de tratamiento. Conclusión El tratamiento de la úlcera venosa crónica es un desafío que requiere contribución colectiva, involucrando a las mujeres, a los profesionales, a los gestores y a las instituciones de salud. .


Objetivo Compreender as experiências e expectativas de enfermeiras no tratamento de mulheres com úlcera venosa crônica na Atenção Primária à Saúde. Método Pesquisa fundamentada na fenomenologia social de Alfred Schütz, com depoimentos obtidos em janeiro de 2012, por meio de entrevista semiestruturada com sete enfermeiras. Resultados As enfermeiras revelam dificuldades apresentadas pelas mulheres com úlcera venosa crônica para realizar o autocuidado, percebem limitações na terapêutica ancoradas na desmotivação e nos valores e crenças das mulheres. Referem frustração profissional em razão da recidiva da lesão, falta de insumos e tecnologia, de trabalho interdisciplinar e da capacitação da equipe de enfermagem. Esperam a adesão das mulheres ao tratamento e ressaltam a necessidade do cuidado contínuo, do autocuidado apoiado e da padronização de condutas no tratamento. Conclusão O tratamento da úlcera venosa crônica constitui-se em um desafio que requer investimento coletivo, envolvendo a mulher, os profissionais, os gestores e as instituições de saúde. .


Assuntos
Animais , Proteínas de Caenorhabditis elegans/isolamento & purificação , Caenorhabditis elegans/metabolismo , Membrana Celular/metabolismo , Canais Iônicos/isolamento & purificação , Canais Iônicos/metabolismo , Proteínas do Tecido Nervoso/isolamento & purificação , Proteínas do Tecido Nervoso/metabolismo , Sistema Nervoso/metabolismo , Neurônios Aferentes/metabolismo , Sensação/genética , Sequência de Aminoácidos/genética , Sequência de Bases/genética , Comportamento Animal/efeitos dos fármacos , Comportamento Animal/fisiologia , Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Caenorhabditis elegans/citologia , Capsaicina/farmacologia , Compartimento Celular/genética , Membrana Celular/efeitos dos fármacos , Membrana Celular/ultraestrutura , Regulação da Expressão Gênica/fisiologia , Canais Iônicos/genética , Canais Iônicos/ultraestrutura , Dados de Sequência Molecular , Mutação/genética , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/ultraestrutura , Sistema Nervoso/citologia , Sistema Nervoso/efeitos dos fármacos , Neurônios Aferentes/citologia , Neurônios Aferentes/efeitos dos fármacos , Dor/genética , Dor/metabolismo , Dor/fisiopatologia , Filogenia , Receptores de Droga/efeitos dos fármacos , Receptores de Droga/metabolismo , Receptores de Droga/ultraestrutura , Sensação/efeitos dos fármacos , Transdução de Sinais/genética , Canais de Cátion TRPV , Canais de Potencial de Receptor Transitório
19.
Proc Natl Acad Sci U S A ; 102(33): 11876-81, 2005 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-16081529

RESUMO

Severe acute respiratory syndrome (SARS) is caused by an emergent coronavirus (SARS-CoV), for which there is currently no effective treatment. SARS-CoV mediates receptor binding and entry by its spike (S) glycoprotein, and infection is sensitive to lysosomotropic agents that perturb endosomal pH. We demonstrate here that the lysosomotropic-agent-mediated block to SARS-CoV infection is overcome by protease treatment of target-cell-associated virus. In addition, SARS-CoV infection was blocked by specific inhibitors of the pH-sensitive endosomal protease cathepsin L. A cell-free membrane-fusion system demonstrates that engagement of receptor followed by proteolysis is required for SARS-CoV membrane fusion and indicates that cathepsin L is sufficient to activate membrane fusion by SARS-CoV S. These results suggest that SARS-CoV infection results from a unique, three-step process: receptor binding and induced conformational changes in S glycoprotein followed by cathepsin L proteolysis within endosomes. The requirement for cathepsin L proteolysis identifies a previously uncharacterized class of inhibitor for SARS-CoV infection.


Assuntos
Catepsinas/antagonistas & inibidores , Inibidores de Proteases/farmacologia , Síndrome Respiratória Aguda Grave/prevenção & controle , Síndrome Respiratória Aguda Grave/virologia , Coronavírus Relacionado à Síndrome Respiratória Aguda Grave/efeitos dos fármacos , Coronavírus Relacionado à Síndrome Respiratória Aguda Grave/fisiologia , Catepsina L , Catepsinas/metabolismo , Linhagem Celular , Membrana Celular/química , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Cisteína Endopeptidases/metabolismo , Humanos , Fusão de Membrana/efeitos dos fármacos , Fusão de Membrana/fisiologia , Estrutura Molecular , Síndrome Respiratória Aguda Grave/enzimologia , Temperatura
20.
Mol Genet Metab ; 71(1-2): 436-44, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11001837

RESUMO

Anthracyclines are a class of highly potent antitumor antibiotics utilized against hematologic and solid tumors in children and in adults. Their use has been limited primarily by their cardiotoxic side effects, which may lead to congestive heart failure. Although there is a linear relationship between the cumulative dose received and the incidence of cardiotoxicity, in some patients cardiotoxicity may develop at doses below the generally accepted threshold level. Anthracycline-induced cardiotoxicity is believed to be related to the generation of highly reactive oxygen species, which, by means of membrane lipid peroxidation, cause direct damage to cardiac myocyte membranes. Another important factor may be the relatively poor antioxidant defense system of the heart. In an attempt to circumvent these toxic effects, a wide variety of antioxidants have been used in cell culture, animal, and human studies without consistent beneficial effects. Moreover, none of the agents used to date are designed to act selectively upon the heart. If the cardiac complications resulting from anthracyclines could be reduced and/or prevented, higher doses could potentially be used, thereby increasing cancer cure rates. Furthermore, the incidence of cardiac toxicity resulting in congestive heart failure or even heart transplantation would be reduced, therefore increasing the quality and extent of life for cancer survivors. This article will review the basic science of free radical biology, the biology of oxygen-derived free radicals and antioxidant proteins, and explore some new and innovative approaches to limiting and/or preventing anthracycline-induced cardiotoxicity.


Assuntos
Antraciclinas/toxicidade , Coração/efeitos dos fármacos , Adulto , Animais , Antioxidantes/metabolismo , Antioxidantes/uso terapêutico , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Criança , Radicais Livres/metabolismo , Insuficiência Cardíaca/induzido quimicamente , Insuficiência Cardíaca/prevenção & controle , Humanos , Peroxidação de Lipídeos , Estresse Oxidativo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA